Cite
HARVARD Citation
Strassman, A. et al. (2022). Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD. Cephalalgia. pp. 933-943. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Strassman, A. et al. (2022). Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD. Cephalalgia. pp. 933-943. [Online].